Posts by: Santiago Gisler

News

Indalo Therapeutics has launched a Phase 1 clinical trial testing the company’s lead antifibrotic candidate IDL-2965 for patients with fibrotic diseases such as idiopathic pulmonary fibrosis (IPF) and nonalcoholic steatohepatitis ... Read more

April 22, 2019April 22, 2019

PFF Summit 2019 in Texas to Present the Latest Research Affecting the PF Community

News

The pulmonary fibrosis (PF) community is invited to attend the Pulmonary Fibrosis Foundation‘s PFF Summit, which is the largest healthcare meeting on PF, offering data on the latest research. ... Read more

April 12, 2019April 12, 2019

Phase 1 Trial Testing PLN-74809 Supports its Clinical Development for IPF Treatment, Pliant Announces

News

Pliant Therapeutics has successfully completed a Phase 1 clinical study assessing its investigational therapy PLN-74809 for idiopathic pulmonary fibrosis (IPF), with results supporting further clinical development of the compound. ... Read more

April 9, 2019April 18, 2019

High Monocyte Levels Linked to Poorer Outcomes in IPF, Other Fibrotic Diseases, Study Finds

News

Blood levels of immune cells called monocytes may help predict disease severity and determine the risk of poor outcomes in patients with idiopathic pulmonary fibrosis (IPF) and other fibrotic diseases, ... Read more

April 5, 2019April 5, 2019

Veracyte’s Envisia Classifier Improves ILD/IPF Diagnosis, Study Says

News

Envisia Genomic Classifier — a non-invasive diagnostic test developed by Veracyte and used as a complement to high-resolution computed tomography (HRCT) imaging — improves diagnosis of interstitial lung disease (ILD) ... Read more

April 3, 2019April 3, 2019

Increased Honeycombing Areas a Prognostic Factor in IPF, Study Finds

News

Quantification of so-called honeycombing areas (patches of cystic spaces) in the lungs seen through high-resolution computed tomography (HRCT) may be a predictor of mortality in people with idiopathic pulmonary ... Read more

March 29, 2019April 18, 2019

Registration Open for Medical Centers with PF Expertise to Join PFF Care Center Network

News

The Pulmonary Fibrosis Foundation (PFF) has opened a new registration cycle for medical centers that wish to join the Foundation’s Care Center Network, with the mission of improving the healthcare ... Read more

March 19, 2019March 22, 2019

Study Finds Increased Risk of PF Among World Trade Center Responders

News

Exposure to dust in the aftermath of the World Trade Center attacks increased the risk of pulmonary fibrosis (PF) among responders, according to an evaluation of self-reported surveys. Researchers found ... Read more

March 13, 2019March 20, 2019

Hydrogel-based Delivery of IL-10 Prevents Lung Fibrosis, Mice Study Finds

News

Linking the small antifibrotic protein interleukin-10 (IL-10) to a hydrogel vehicle allows safe delivery to the lungs of animal models of pulmonary fibrosis. This formulation could be a potential ... Read more

March 6, 2019March 8, 2019

CT-measured Muscle Mass Index May Predict Outcomes in IPF Patients, Study Suggests

News

Measuring the loss of skeletal muscle mass in the thoracic area using computed tomography (CT) scans may predict clinical outcomes such as survival in patients with idiopathic pulmonary fibrosis ... Read more

Posts by: Santiago Gisler

Santiago Gisler

Indalo Therapeutics Starts Phase 1 Trial Testing Antifibrotic Candidate IDL-2965

PFF Summit 2019 in Texas to Present the Latest Research Affecting the PF Community

Phase 1 Trial Testing PLN-74809 Supports its Clinical Development for IPF Treatment, Pliant Announces

High Monocyte Levels Linked to Poorer Outcomes in IPF, Other Fibrotic Diseases, Study Finds

Veracyte’s Envisia Classifier Improves ILD/IPF Diagnosis, Study Says

Increased Honeycombing Areas a Prognostic Factor in IPF, Study Finds

Registration Open for Medical Centers with PF Expertise to Join PFF Care Center Network

Study Finds Increased Risk of PF Among World Trade Center Responders

Hydrogel-based Delivery of IL-10 Prevents Lung Fibrosis, Mice Study Finds

CT-measured Muscle Mass Index May Predict Outcomes in IPF Patients, Study Suggests

Pin It on Pinterest